AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans Phase I results provide platform-level validation supporting AdJane’s broader development Read More
CARB-X Awards US$2.6 million funding to AdJane CARB-X awards funding to AdJane to advance its nOMV platform-derived Read More
